Tacrolimus, modified release
Phase 3Completed 0 watching 0 views this week๐ Rising
77
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 24
Phase 35
ApprovedIndication / Disease
Kidney Transplantation
Conditions
Kidney Transplantation
Trial Timeline
Sep 1, 2007 โ Dec 1, 2007
NCT ID
NCT00865137About Tacrolimus, modified release
Tacrolimus, modified release is a phase 3 stage product being developed by Astellas Pharma for Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00865137. Target conditions include Kidney Transplantation.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00865137 | Phase 3 | Completed |
Competing Products
20 competing products in Kidney Transplantation